Detalhe da pesquisa
1.
Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial.
Catheter Cardiovasc Interv
; 93(1): E1-E7, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30286520